BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 24075824)

  • 1. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.
    Son T; Hyung WJ; Lee JH; Kim YM; Kim HI; An JY; Cheong JH; Noh SH
    Cancer; 2012 Oct; 118(19):4687-93. PubMed ID: 22415925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
    Biondi A; D'Ugo D; Cananzi FC; Papa V; Borasi A; Sicoli F; Degiuli M; Doglietto G; Persiani R
    Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphadenectomy in patients with gastric cancer. A critical review.
    Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
    Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
    Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
    Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
    Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
    Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.
    Huscher CG; Mingoli A; Sgarzini G; Sansonetti A; Lirici MM; Napolitano C; Piro F
    Am J Surg; 2004 Dec; 188(6):728-35. PubMed ID: 15619491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
    Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection.
    Sun Z; Xu Y; Li de M; Wang ZN; Zhu GL; Huang BJ; Li K; Xu HM
    Cancer; 2010 Jun; 116(11):2571-80. PubMed ID: 20336791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients.
    Yamashita H; Deng J; Liang H; Seto Y
    Surgery; 2017 Jun; 161(6):1588-1596. PubMed ID: 28111043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
    Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
    Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer.
    Sarela AI; Brennan MF; Karpeh MS; Klimstra D; Conlon KC
    Ann Surg Oncol; 2004 Apr; 11(4):380-6. PubMed ID: 15070597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection.
    Biffi R; Botteri E; Cenciarelli S; Luca F; Pozzi S; Valvo M; Sonzogni A; Chiappa A; Leal Ghezzi T; Rotmensz N; Bagnardi V; Andreoni B
    Eur J Surg Oncol; 2011 Apr; 37(4):305-11. PubMed ID: 21288685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma?
    Aurello P; Petrucciani N; Nigri GR; La Torre M; Magistri P; Tierno S; D'Angelo F; Ramacciato G
    J Gastrointest Surg; 2014 Jul; 18(7):1254-60. PubMed ID: 24841441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.